Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake
Johanna M Poller,1,2 Jan Zaloga,1 Eveline Schreiber,1 Harald Unterweger,1 Christina Janko,1 Patricia Radon,3 Dietmar Eberbeck,3 Lutz Trahms,3 Christoph Alexiou,1 Ralf P Friedrich1 1Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology & Nanomedicine (SE...
Guardado en:
Autores principales: | Poller JM, Zaloga J, Schreiber E, Unterweger H, Janko C, Radon P, Eberbeck D, Trahms L, Alexiou C, Friedrich RP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bdb8c2a535b24457a56b573277729452 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models
por: Lugert S, et al.
Publicado: (2018) -
Intracellular Quantification and Localization of Label-Free Iron Oxide Nanoparticles by Holotomographic Microscopy
por: Friedrich RP, et al.
Publicado: (2020) -
Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
por: Unterweger H, et al.
Publicado: (2017) -
Preparation and in vitro Evaluation of Doxorubicin-Loaded Fe3O4 Magnetic Nanoparticles Modified with Biocompatible Copolymers [Retraction]
por: Akbarzadeh A, et al.
Publicado: (2020) -
A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model
por: Klapproth AP, et al.
Publicado: (2020)